EUVIMEDOpdag EUVIMED
Crossref

Silver secnidazole nano‐hybrid emulsion‐based probiotics as a novel antifungal formula against multidrug‐resistant vaginal pathogens

Farag M Mosallam iD, Eman A Helmy iD, Hanan S El-Bastawisy iD, Ahmed I El-Batal

Biotechnology and Applied Biochemistry · 2025

DOI: 10.1002/bab.2663 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, 2025. Written by Farag M Mosallam and 3 co-authors. Institution: Division of Biotechnology, Microbiology Lab, Department of Drug Radiation Research, National Center for Radiation Research and Technology, Egyptian A…. Major MEDLINE topics: Probiotics, Antifungal Agents, Silver, Candida albicans. Cited 2 times so far (Crossref); 82 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This study presents a novel approach to manage vaginal infections due to Candidiasis, utilizing a novel silver secnidazole nano‐hybrid emulsion (Ag‐Secn‐NHE)‐based probiotics and free Ag‐Secn‐NHE. Ag‐Secn‐NHE was prepared by simple homogenization‒ultrasonication technique and validated by using a ultraviolet‒visible scan, dynamic light scattering, transmission electron microscopy (TEM), Fourier‐transform infrared spectroscopy, and zeta potential. Saccharomyces cerevisiae (RCMB 002Y001) is the most effective probiotic‐producing organism that demonstrates significant effects when combined with Ag‐Secn‐NHE. Ag‐Secn‐NHE‐based probiotics showed significant antifungal effect compared to free Ag‐Secn‐NHE, silver nitrate, silver nanoparticles, secnidazole, secnidazole nanoemulsion, and commercial vaginal wash against multidrug‐resistant vaginal pathogens. The highest inhibitory effect was achieved with Ag‐Secn‐NHE‐based probiotic against Candida auris , Candida albicans , and Cryptococcus neoformans with minimal inhibitory concentration (MIC) 0.625 ± 0.002, 0.00625:1.25 ± 0.012 and 0.00625:1.25 ± 0.032 mg/mL, respectively, in comparison with Ag‐Secn‐NHE that show MIC at 0.00625:1.25 ± 0.612, 0.0125:2.5 ± 0.812, and 0.0125:2.5 ± 0.112 mg/mL (Ag:Secn). Ag‐Secn‐NHE‐based‐ probiotic show minimum fungicidal concentration (MFC) at range from 2.5 to 20 mg/mL, wherever free Ag‐Secn‐NHE show MFC range from 5 to >20 mg/mL. Additionally, Ag‐Secn‐NHE‐based probiotics have 75% inhibition of biofilm formation against C. auris and 60% inhibition of biofilm formation against both Cryptococcus neoformans and C. albicans in comparison with free Ag‐Secn‐NHE. Time‐kill curves showed that the antifungal effect of Ag‐Secn‐NHE‐based probiotics was fungistatic at 2MIC value after 4 h and after 16 h for Ag‐Secn‐NHE. TEM photographs showed that C. auris cells treated with Ag‐Secn‐NHE‐based probiotic formula revealed severe deformations and distored ultrastructural changes. furthermore, results indicated that the Gamma radiation up to 15 kGy increases production of Ag‐Secn‐NHE in comparison with non‐irradiated one.

Subjects

MeSH terms (MEDLINE)

ProbioticsAntifungal AgentsSilverCandida albicansMetronidazoleCryptococcus neoformansVaginaMetal NanoparticlesEmulsionsFemaleMicrobial Sensitivity TestsHumansCandida aurisSaccharomyces cerevisiae

Author keywords

probiotics and gamma radiationsilver secnidazole nano‐hybrid emulsionvulvovaginal candidiasis

Substances

EmulsionsAntifungal AgentsSilverMetronidazolesecnidazole

Authors and institutions

  • Division of Biotechnology, Microbiology Lab, Department of Drug Radiation Research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Regional Center for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt.

ORCID profiles: Farag M Mosallam, Eman A Helmy, Hanan S El-Bastawisy

Cite

APA

Mosallam, F. M., Helmy, E. A., El-Bastawisy, H. S., & El-Batal, A. I. (2025). Silver secnidazole nano‐hybrid emulsion‐based probiotics as a novel antifungal formula against multidrug‐resistant vaginal pathogens. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2663

Vancouver

Mosallam FM, Helmy EA, El-Bastawisy HS, El-Batal AI. Silver secnidazole nano‐hybrid emulsion‐based probiotics as a novel antifungal formula against multidrug‐resistant vaginal pathogens. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2663

BibTeX
@article{Mosallam2025,
  author = {Mosallam, Farag M and Helmy, Eman A and El-Bastawisy, Hanan S and El-Batal, Ahmed I},
  title = {Silver secnidazole nano‐hybrid emulsion‐based probiotics as a novel antifungal formula against multidrug‐resistant vaginal pathogens},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2025},
  doi = {10.1002/bab.2663}
}
Start for free →